Evidence map›Paper›PMID 29491408›Full record

ArticleScientific reports2018

Nox4 is a Target for Tuberin Deficiency Syndrome.

Qian Shi, Suryavathi Viswanadhapalli, William E Friedrichs, Chakradhar Velagapudi, Cédric Szyndralewiez, Shweta Bansal, Manzoor A Bhat, Goutam Ghosh Choudhury, Hanna E Abboud

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qian ShiDepartments of Medicine/Division of Nephrology, University of Texas Health San Antonio, San Antonio, Texas, USA. shiq@uthscsa.edu.
Suryavathi ViswanadhapalliDepartments of Medicine/Division of Nephrology, University of Texas Health San Antonio, San Antonio, Texas, USA.
William E FriedrichsDepartments of Medicine/Division of Nephrology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Chakradhar VelagapudiDepartments of Medicine/Division of Nephrology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Cédric SzyndralewiezGenkyotex SA, Geneva, Switzerland.
Shweta BansalDepartments of Medicine/Division of Nephrology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Manzoor A BhatDepartment of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Goutam Ghosh ChoudhuryDepartments of Medicine/Division of Nephrology, University of Texas Health San Antonio, San Antonio, Texas, USA. choudhuryg@uthscsa.edu.
Hanna E AbboudDepartments of Medicine/Division of Nephrology, University of Texas Health San Antonio, San Antonio, Texas, USA.

Funding

Mechanism of Renal Cell Injury in DiabetesR01DK050190 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GHOSH CHOUDHURY, GOUTAM · 2004 to 2013
$2.3M
Tubular epithelial cell injuryR01DK033665 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GORIN, YVES CLAUDE · 1986 to 2015
$1.3M
Mechanisms of Renal Cell InjuryI01BX000926 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI GHOSH CHOUDHURY, GOUTAM, SHARMA, KUMAR · 2011 to 2024
–
Renal Fibrosis in DiabetesI01BX001815 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI BARNES, JEFFREY L · 2013 to 2016
–
BLR&D Research Career Scientist Award ApplicationIK6BX003611 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI GHOSH CHOUDHURY, GOUTAM · 2017 to 2021
–
BLRD VA I01 BX000926BLRD VA I01 BX001815BLRD VA IK6 BX003611NIDDK NIH HHS R01 DK033665NIDDK NIH HHS R01 DK050190
6 · The paper itself

Abstract

The mechanism by which TSC2 inactivation or deficiency contributes to the pathology of tuberous sclerosis complex (TSC) is not fully clear. We show that renal angiomyolipomas from TSC patients and kidney cortex from Tsc2+/- mice exhibit elevated levels of reactive oxygen species (ROS). Downregulation of tuberin (protein encoded by TSC2 gene) in renal proximal tubular epithelial cells significantly increased ROS concomitant with enhanced Nox4. Similarly, we found elevated levels of Nox4 in the renal cortex of Tsc2+/- mice and in the renal angiomyolipomas from TSC patients. Tuberin deficiency is associated with activation of mTORC1. Rapamycin, shRNAs targeting raptor, or inhibition of S6 kinase significantly inhibited the expression of Nox4, resulting in attenuation of production of ROS in tuberin-downregulated proximal tubular epithelial cells. In contrast, activation of mTORC1 increased Nox4 and ROS. These results indicate that Nox4 may be a potential target for tuberin-deficiency-derived diseases. Using a xenograft model from tuberin-null tubular cells in nude mice, both anti-sense Nox4 and GKT137831, a specific inhibitor of Nox1/4, significantly inhibited the tumor growth. Thus, our results demonstrate the presence of an antagonistic relationship between tuberin and Nox4 to drive oncogenesis in the tuberin deficiency syndrome and identify Nox4 as a target to develop a therapy for TSC.

Indexed as

AngiomyolipomaAnimalsCase-Control StudiesHumansKidneyKidney DiseasesMaleMiceMice, NudeNADPH Oxidase 4Reactive Oxygen SpeciesSyndromeTuberous SclerosisTuberous Sclerosis Complex 2 ProteinXenograft Model Antitumor AssaysNADPH Oxidase 4Reactive Oxygen SpeciesTuberous Sclerosis Complex 2 Protein

Identifiers

PMID29491408
PMCPMC5830489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.